×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
Gynecology / Ovaries peritoneum / Webinar
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateurs : Laurence Gladieff & Gwenaël Ferron

 

Au programme de cette soirée

18:00 Introduction
Gwenaël Ferron
 
18:05 Comment juger de l'intérêt d'un traitement par iPARP ?
1. Testing HRD, NGS, Guillaume Bataillon
2. KELIM, Benoit You
 
18:30 Survie à long terme avec les iPARPs : vers la guérison ?
Isabelle Ray-Coquard
 
18:55 Pourquoi les inhibiteurs de PARP ne fonctionnent-ils pas toujours ?
Laurence Gladieff
 
19:20 Débat/Discussion et réponses aux questions
 

 

Shooting date : 2022-11-16
Last update : 2022-11-17
Guillaume Bataillon
Toulouse, France
Private message
Gwenaël Ferron
Toulouse, France
Private message
Laurence Gladieff
Toulouse, France
Private message
Isabelle Ray-Coquard
Lyon, France
Private message
Benoit You
Lyon, France
Private message
Be the first to comment

Suggestions

Wednesday, April 9th 2025 from 01pm to 01:45pm (GMT+2)
Honolulu : Wednesday, April 9th 2025 from 01am to 01:45am (GMT+2)
San Francisco : Wednesday, April 9th 2025 from 04am to 04:45am (GMT+2)
New York : Wednesday, April 9th 2025 from 07am to 07:45am (GMT+2)
Buenos Aires : Wednesday, April 9th 2025 from 08am to 08:45am (GMT+2)
Reykjavik : Wednesday, April 9th 2025 from 11am to 11:45am (GMT+2)
London / Dublin : Wednesday, April 9th 2025 from 12pm to 12:45pm (GMT+2)
Paris / Berlin : Wednesday, April 9th 2025 from 01pm to 01:45pm (GMT+2)
Istanbul : Wednesday, April 9th 2025 from 02pm to 02:45pm (GMT+2)
Moscou / Dubaï : Wednesday, April 9th 2025 from 03pm to 03:45pm (GMT+2)
Bangkok : Wednesday, April 9th 2025 from 06pm to 06:45pm (GMT+2)
Shanghai : Wednesday, April 9th 2025 from 07pm to 07:45pm (GMT+2)
Tokyo : Wednesday, April 9th 2025 from 08pm to 08:45pm (GMT+2)
Sydney : Wednesday, April 9th 2025 from 10pm to 10:45pm (GMT+2)
Wellington : Thursday, April 10th 2025 from 12am to 12:45am (GMT+2)

Comment prendre en charge un cancer de l'endomètre avancé ?

Cancer de l’endomètre avancé pMMR P53 muté (épisode 3)

Gynecology / Ovaries peritoneum / Webinar
View more
Share
Saturday, March 22nd 2025 from 09:30am to 12:30pm (GMT+1)
Honolulu : Friday, March 21st 2025 from 09:30pm to 12:30am (GMT+1)
San Francisco : Friday, March 21st 2025 from 11:30pm to 02:30am (GMT+1)
New York : Saturday, March 22nd 2025 from 02:30am to 05:30am (GMT+1)
Buenos Aires : Saturday, March 22nd 2025 from 04:30am to 07:30am (GMT+1)
London / Dublin : Saturday, March 22nd 2025 from 07:30am to 10:30am (GMT+1)
Paris / Berlin : Saturday, March 22nd 2025 from 08:30am to 11:30am (GMT+1)
Istanbul : Saturday, March 22nd 2025 from 09:30am to 12:30pm (GMT+1)
Moscou / Dubaï : Saturday, March 22nd 2025 from 11:30am to 02:30pm (GMT+1)
Bangkok : Saturday, March 22nd 2025 from 02:30pm to 05:30pm (GMT+1)
Shanghai : Saturday, March 22nd 2025 from 03:30pm to 06:30pm (GMT+1)
Tokyo : Saturday, March 22nd 2025 from 04:30pm to 07:30pm (GMT+1)
Sydney : Saturday, March 22nd 2025 from 05:30pm to 08:30pm (GMT+1)
Wellington : Saturday, March 22nd 2025 from 07:30pm to 10:30pm (GMT+1)

Transpyrenean Oncogynae Symposium

Ovarian cancer: from molecular insights to multidisciplinary strategies

Gynecology / Ovaries peritoneum / Conference
View more
Share
Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, December 13th 2022 from 06am to 07:30am (GMT+1)
San Francisco : Tuesday, December 13th 2022 from 08am to 09:30am (GMT+1)
New York : Tuesday, December 13th 2022 from 11am to 12:30pm (GMT+1)
Buenos Aires : Tuesday, December 13th 2022 from 01pm to 02:30pm (GMT+1)
London / Dublin : Tuesday, December 13th 2022 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Tuesday, December 13th 2022 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Tuesday, December 13th 2022 from 08pm to 09:30pm (GMT+1)
Bangkok : Tuesday, December 13th 2022 from 11pm to 12:30am (GMT+1)
Shanghai : Wednesday, December 14th 2022 from 12am to 01:30am (GMT+1)
Tokyo : Wednesday, December 14th 2022 from 01am to 02:30am (GMT+1)
Sydney : Wednesday, December 14th 2022 from 02am to 03:30am (GMT+1)
Wellington : Wednesday, December 14th 2022 from 04am to 05:30am (GMT+1)

Last improvements in advanced ovarian cancer treatment

Trials that have or will impact practices in the management of patients with advanced ovarian cancer

Gynecology / Ovaries peritoneum / Webinar
View more
Share
Tuesday, October 11th 2022 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, October 11th 2022 from 06am to 07:30am (GMT+2)
San Francisco : Tuesday, October 11th 2022 from 09am to 10:30am (GMT+2)
New York : Tuesday, October 11th 2022 from 12pm to 01:30pm (GMT+2)
Buenos Aires : Tuesday, October 11th 2022 from 01pm to 02:30pm (GMT+2)
Reykjavik : Tuesday, October 11th 2022 from 04pm to 05:30pm (GMT+2)
London / Dublin : Tuesday, October 11th 2022 from 05pm to 06:30pm (GMT+2)
Paris / Berlin : Tuesday, October 11th 2022 from 06pm to 07:30pm (GMT+2)
Istanbul : Tuesday, October 11th 2022 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Tuesday, October 11th 2022 from 08pm to 09:30pm (GMT+2)
Bangkok : Tuesday, October 11th 2022 from 11pm to 12:30am (GMT+2)
Shanghai : Wednesday, October 12th 2022 from 12am to 01:30am (GMT+2)
Tokyo : Wednesday, October 12th 2022 from 01am to 02:30am (GMT+2)
Sydney : Wednesday, October 12th 2022 from 03am to 04:30am (GMT+2)
Wellington : Wednesday, October 12th 2022 from 05am to 06:30am (GMT+2)

Cancer de l’ovaire

Gynecology / Ovaries peritoneum / Webinar/3 Comments
View more
Share
Scroll Up